Literature DB >> 11356986

Long-circulating and target-specific nanoparticles: theory to practice.

S M Moghimi1, A C Hunter, J C Murray.   

Abstract

The rapid recognition of intravenously injected colloidal carriers, such as liposomes and polymeric nanospheres from the blood by Kupffer cells, has initiated a surge of development for "Kupffer cell-evading" or long-circulating particles. Such carriers have applications in vascular drug delivery and release, site-specific targeting (passive as well as active targeting), as well as transfusion medicine. In this article we have critically reviewed and assessed the rational approaches in the design as well as the biological performance of such constructs. For engineering and design of long-circulating carriers, we have taken a lead from nature. Here, we have explored the surface mechanisms, which affords red blood cells long-circulatory lives and the ability of specific microorganisms to evade macrophage recognition. Our analysis is then centered where such strategies have been translated and fabricated to design a wide range of particulate carriers (e.g., nanospheres, liposomes, micelles, oil-in-water emulsions) with prolonged circulation and/or target specificity. With regard to the targeting issues, attention is particularly focused on the importance of physiological barriers and disease states.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356986

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  635 in total

Review 1.  Nanoparticle mediated non-covalent drug delivery.

Authors:  Tennyson Doane; Clemens Burda
Journal:  Adv Drug Deliv Rev       Date:  2012-06-01       Impact factor: 15.470

2.  In vivo evaluation of doxorubicin-loaded (PEG)(3)-PLA nanopolymersomes (PolyDoxSome) using DMBA-induced mammary carcinoma rat model and comparison with marketed LipoDox™.

Authors:  Wubeante Yenet Ayen; Neeraj Kumar
Journal:  Pharm Res       Date:  2012-06-06       Impact factor: 4.200

3.  Blood-nanoparticle interactions and in vivo biodistribution: impact of surface PEG and ligand properties.

Authors:  Neha B Shah; Gregory M Vercellotti; James G White; Adrian Fegan; Carston R Wagner; John C Bischof
Journal:  Mol Pharm       Date:  2012-07-23       Impact factor: 4.939

4.  Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models.

Authors:  Xuelei Yin; Yingying Chi; Chuanyou Guo; Shuaishuai Feng; Jinhu Liu; Kaoxiang Sun; Zimei Wu
Journal:  Pharm Res       Date:  2017-07-19       Impact factor: 4.200

5.  PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1.

Authors:  Na Zhang; Chuda Chittasupho; Chadarat Duangrat; Teruna J Siahaan; Cory Berkland
Journal:  Bioconjug Chem       Date:  2007-11-13       Impact factor: 4.774

6.  Bioavailability effect of methylprednisolone by polymeric micelles.

Authors:  Ching-Lin Chen; Shwu-Fen Chang; Daniel Lee; Lang-Yo Yang; Yi-Hsuan Lee; Chung Y Hsu; Shwu-Jiuan Lin; Jiahorng Liaw
Journal:  Pharm Res       Date:  2007-11-08       Impact factor: 4.200

7.  NIR-emissive PEG-b-TCL micelles for breast tumor imaging and minimally invasive pharmacokinetic analysis.

Authors:  Christina L Hofmann; Melanie C O'Sullivan; Alexandre Detappe; Yingjie Yu; Xi Yang; Wei Qi; Chelsea D Landon; Michael J Therien; Mark W Dewhirst; P Peter Ghoroghchian; Gregory M Palmer
Journal:  Nanoscale       Date:  2017-09-21       Impact factor: 7.790

8.  Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.

Authors:  Marina A Dobrovolskaia; Anil K Patri; Jiwen Zheng; Jeffrey D Clogston; Nader Ayub; Parag Aggarwal; Barry W Neun; Jennifer B Hall; Scott E McNeil
Journal:  Nanomedicine       Date:  2008-12-13       Impact factor: 5.307

9.  Multifunctional to multistage delivery systems: The evolution of nanoparticles for biomedical applications.

Authors:  Jonathan O Martinez; Brandon S Brown; Nicoletta Quattrocchi; Michael Evangelopoulos; Mauro Ferrari; Ennio Tasciotti
Journal:  Chin Sci Bull       Date:  2012-11-01

10.  Targeted killing of cancer cells in vivo and in vitro with EGF-directed carbon nanotube-based drug delivery.

Authors:  Ashwin A Bhirde; Vyomesh Patel; Julie Gavard; Guofeng Zhang; Alioscka A Sousa; Andrius Masedunskas; Richard D Leapman; Roberto Weigert; J Silvio Gutkind; James F Rusling
Journal:  ACS Nano       Date:  2009-02-24       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.